Metabolic, metallic, and mitotic sources of oxidative stress in Alzheimer disease

Antioxidants and Redox Signaling

Volumn 2, Issue 3, 2000, Pages 413-420

  Smith, M A ^a   Nunomura, A ^b   Zhu, X ^a   Takeda, A ^a   Perry, G ^a  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

^b ASAHIKAWA MEDICAL COLLEGE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DIMETHYLARGININASE; FERROUS GLUCONATE; HEME OXYGENASE; HYDROGEN PEROXIDE; IRON; METAL DERIVATIVE; MITOCHONDRIAL DNA; REACTIVE OXYGEN METABOLITE; REGULATOR PROTEIN;

ALZHEIMER DISEASE; BINDING SITE; LIPID PEROXIDATION; METABOLISM; MITOSIS; NERVE CELL NECROSIS; NEUROFIBRILLARY TANGLE; NITRATION; OXIDATION REDUCTION POTENTIAL; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN CONFORMATION; REVIEW;

EID: 0033751421     PISSN: 15230864     EISSN: None     Source Type: Journal    
DOI: 10.1089/15230860050192198     Document Type: Review

References (56)

1. Alzheimer's disease hyperphosphorylated tau sequesters normal tau into tangles of filaments and disassembles microtubules
2. Increased expression and subcellular translocation of the mitogen activated protein kinase kinase and mitogen-activated protein kinase in Alzheimer's disease
3. Expression of the cyclin-dependent kinase inhibitor p16 in Alzheimer's disease
4. Static cytofluorometry and fluorescence morphology of mitochondria and DNA in proliferating fibroblasts
5. Immunologic determinants of tau protein are present in neurofibrillary tangles of Alzheimer's disease
6. Distribution of the phosphorylated microtubule-associated protein tau in developing cortical neurons
7. Expression vectors employing A, trp, lac, and pp-derived promoters
8. Multiple roles of glutathione in the central nervous system
9. Extracellular neurofibrillary tangles reflect neuronal loss and provide further evidence of extensive protein cross-linking in Alzheimer disease
10. Microtubule dysfunction by post-translational nitrotyrosination of alpha-tubulin: A nitric oxide-dependent mechanism of cellular injury
11. The abnormal phosphorylation of tau protein at Ser-202 in Alzheimer disease recapitulates phosphorylation during development
12. Apolipoprotein E is present in hippocampal neurons without neurofibrillary tangles in Alzheimer's disease and in age-matched controls
13. A model for β-amyloid aggregation and neurotoxicity based on free radical generation by the peptide: Relevance to Alzheimer disease
14. Neuronal RNA oxidation and mitochondrial proliferation denote profound metabolic abnormalities in Alzheimer disease
15. Presenilin overexpression arrests cells in the G1 phase of the cell cycle. Arrest potentiated by the Alzheimer's disease PS2(N141I)mutant
16. Fetal-type phosphorylation of the tau in paired helical filaments
17. Amyloid precursor protein in peripheral mononuclear cells is upregulated with cell activation
18. Alzheimer presenilins in the nuclear membrane, interphase kinetochores, and centrosomes suggest a role in chromosome segregation
19. Phosphorylation affects the ability of tau protein to promote microtubule assembly
20. Oxidative stress hypothesis in Alzheimer's disease
21. A tombstone in Alzheimer's?
22. β-Amyloid fibrils activate parallel mitogen-activated protein kinase pathways in microglia and THP1 monocytes
23. Abnormal expression of the cell cycle regulators P16 and CDk4 in Alzheimer's disease
24. Apolipoprotein E allele-specific antioxidant activity and effects on cytotoxicity by oxidative insults and β-amyloid peptides
25. Neurons may live for decades with neurofibrillary tangles
26. Copper-binding amyloid precursor undergoes a site-specific fragmentation in the reduction of hydrogen peroxide
27. Expression of cell division markers in the hippocampus in Alzheimer's disease and other neurodegenerative conditions
28. Cell cycle markers in the hippocampus in Alzheimer's disease
29. RNA oxidation is a prominent feature of vulnerable neurons in Alzheimer's disease
30. Neuronal RNA oxidation in Alzheimer disease and Down's syndrome
31. Structure and synthesis of the ribosomal ribonucleic acid of prokaryotes
32. The case for vascular abnormalities in Alzheimer's disease
33. Reactive oxygen species mediate cellular damage in Alzheimer disease
34. Cerebrovascular muscle atropy is a feature of Alzheimer's disease
35. A suicide note from Alzheimer disease neurons?
36. Apoptosis and Alzheimer's disease
37. Microtubule-associated protein tau is hyperphosphorylated during mitosis in the human neuroblastoma cell line SH-SY5Y
38. Mitogen-activated protein kinases activated by lipopolysaccharide and beta-amyloid in cultured rat microglia
39. Quinone reductase (NQO1), a sensitive redox indicator, is increased in Alzheimer's disease
40. Increased neuronal glucose-6-phosphate dehydrogenase and sulfhydrl levels indicate reductive compensation to oxidative stress in Alzheimer disease
41. In situ redox catalysis by neurofibrillary tangles and senile plaques in Alzheimer disease: Initial efforts to distinguish iron versus copper
42. Apolipoprotein E epsilon4 and the risk of dementia with stroke. A population-based investigation
43. Alzheimer disease
44. Protein modifications and interactions in Alzheimer's disease
45. Advanced Maillard reaction products are associated with Alzheimer disease pathology
46. Radical AGEing in Alzheimer's disease
47. Iron accumulation in Alzheimer disease is a source of redox-generated free radicals
48. Widespread peroxynitrite-mediated damage in Alzheimer's disease
49. Developmental changes in calcium content of ultrastructurally distinct subcellular compartments of preimplantation human embryos
50. Coronary artery disease, hypertension, ApoE, and cholesterol: A link to Alzheimer's disease?
51. Basement membrane proteins, apolipoprotein E and glycosaminoglycans in pituitary adenomas and their correlation to amyloid
52. Cell cycle-dependent regulation of the phosphorylation and metabolism of the Alzheimer amyloid precursor protein
53. In Alzheimer disease, heme oxygenase is coincident with Alz50, an epitope of tau induced by 4-hydroxy-2-nonenal modification
54. Mitotic mechanisms in Alzheimer's disease?
55. Advanced glycation end products contribute to amyloidosis in Alzheimer disease
56. Cell cycle events in neurons: Proliferation or death?